|
|
|
13.11.26 - 09:36
|
Direct Line drives 19% premium surge at Aviva (ShareCast)
|
|
|
Aviva said it expected earnings per share to grow broadly in line with its 11% target this year after general insurance premiums grew 19% to almost £12bn in the first nine months of the year driven by Direct Line and the new home ins...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.10.26 - 08:54
|
Aviva Issues Guidance For Wealth Business (AFX)
|
|
|
LONDON (dpa-AFX) - Aviva plc (AV.L) said it has delivered a strong performance in its Wealth business since the last Wealth 'In Focus' briefing in 2023. The Group said it is on track for ambition ......
|
|
|
29.09.26 - 11:36
|
New UK homes in flood-risk areas could become uninsurable, says Aviva boss (The Guardian)
|
|
|
Amanda Blanc says flooding threat is 'absolutely increasing', as she also warns ministers over 'kite flying' before budgetBusiness live – latest updatesThe boss of Britain's biggest insurer has warned that homes being built now could become uninsurable in the future because they are sited in flood-risk areas.Amanda Blanc, the chief executive of Aviva, said the flooding threat was “absolutely increasing”. Assuming current construction patterns continue, 115,000 homes will be built in flood zones in the next decade. Continue reading......
|
|
|
29.09.26 - 11:06
|
Institute for Protein Innovation Appoints Kevin J. Harvey, Ph.D., as President and Chief Executive Officer (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--The Institute for Protein Innovation (IPI), a nonprofit research organization advancing protein science to accelerate biomedical research and improve human health, today announced the appointment of Kevin J. Harvey, Ph.D., as President and Chief Executive Officer.
Dr. Harvey joins IPI from Aviva Systems Biology, bringing more than two decades of leadership and research experience focused on antibodies, protein research, and life science research tools. The IPI Board believes Dr. Harvey is well positioned to lead the Institute through its next phase of growth as it expands its recombinant antibody platform, develops new protein tools for neuroscience and extends its protein engineering expertise to more researchers across the life sciences community.
“IPI has built something unique: a model and platform that researchers worldwide can already access,” said Dr. Harvey. “I'm joining at this pivotal moment, when the foundation is strong and the impact imminent. We want to reach ...
|
|
|
09.09.26 - 13:42
|
Aviva Investors ordnet Aktienbereich neu - Fondsnews (Fondscheck)
|
|
|
Wien (www.fondscheck.de) - Aviva Investors bündelt seine Aktienkompetenzen künftig unter einer einheitlichen Führungsstruktur, so die Experten von "FONDS professionell".
Im Zuge der Neuorganisation werde das Index-Investments-Team in den von Nicholette MacDonald-Brown geleiteten Equity-Bereich integriert. [mehr]...
|
|
|
08.09.26 - 09:45
|
Aviva Investors verstärkt Aktien-Team (Fundresearch)
|
|
|
Aviva Investors baut seine Aktienkompetenz um. Luciano Lilloy übernimmt eine neu geschaffene Position als Head of Sustainable Equities. Duncan Bulgin wird neuer Head of Equity Research und folgt auf Max Burns, der in den Ruhestand geht....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
